- Home
- ISPR vs ZBIO Comparison
ISPR vs ZBIO Comparison
Compare ISPR & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- ZBIO
- Stock Information
- Founded
- ISPR 2019
- ZBIO 2019
- Country
- ISPR United States
- ZBIO United States
- Employees
- ISPR N/A
- ZBIO N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- ZBIO
- Sector
- ISPR Health Care
- ZBIO
- Exchange
- ISPR Nasdaq
- ZBIO NYSE
- Market Cap
- ISPR 286.1M
- ZBIO 339.3M
- IPO Year
- ISPR 2023
- ZBIO 2024
- Fundamental
- Price
- ISPR $4.55
- ZBIO $7.85
- Analyst Decision
- ISPR Strong Buy
- ZBIO Strong Buy
- Analyst Count
- ISPR 1
- ZBIO 5
- Target Price
- ISPR $12.50
- ZBIO $31.75
- AVG Volume (30 Days)
- ISPR 74.9K
- ZBIO 390.2K
- Earning Date
- ISPR 02-18-2025
- ZBIO 02-16-2025
- Dividend Yield
- ISPR N/A
- ZBIO N/A
- EPS Growth
- ISPR N/A
- ZBIO N/A
- EPS
- ISPR N/A
- ZBIO N/A
- Revenue
- ISPR $148,382,357.00
- ZBIO N/A
- Revenue This Year
- ISPR $23.73
- ZBIO N/A
- Revenue Next Year
- ISPR $75.56
- ZBIO N/A
- P/E Ratio
- ISPR N/A
- ZBIO N/A
- Revenue Growth
- ISPR 12.82
- ZBIO N/A
- 52 Week Low
- ISPR $4.35
- ZBIO $7.50
- 52 Week High
- ISPR $12.14
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- ISPR 34.87
- ZBIO N/A
- Support Level
- ISPR $4.35
- ZBIO N/A
- Resistance Level
- ISPR $4.98
- ZBIO N/A
- Average True Range (ATR)
- ISPR 0.32
- ZBIO 0.00
- MACD
- ISPR -0.02
- ZBIO 0.00
- Stochastic Oscillator
- ISPR 15.61
- ZBIO 0.00
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.